SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-18-045455
Filing Date
2018-08-03
Accepted
2018-08-03 21:28:59
Documents
1
Period of Report
2018-08-01

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 5662
  Complete submission text file 0001209191-18-045455.txt   7029
Mailing Address 257 SIMARANO DRIVE SUITE 101 MARLBOROUGH MA 01752
Business Address 257 SIMARANO DRIVE SUITE 101 MARLBOROUGH MA 01752 (508) 767-3861
RXi Pharmaceuticals Corp (Issuer) CIK: 0001533040 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 257 SIMARANO DRIVE, SUITE 101 MARLBOROUGH MA 01752
Business Address
Dispersyn Gerrit (Reporting) CIK: 0001704417 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36304 | Film No.: 18993333